Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Evaluate Efficacy and Safety of Transdermal Testosterone and Safety for an Open-label Period in Women With Hypoactive Sexual Desire Disorder on Estrogen Replacement Therapy and Undergone Hysterectomy/Bilateral Oophorectomy.

NCT00331123 is registered in ClinicalTrials.gov with Warner Chilcott as lead sponsor.

NCT NCT00331123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00331123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Evaluate Efficacy and Safety of Transdermal Testosterone and Safety for an Open-label Period in Women With Hypoactive Sexual Desire Disorder on Estrogen Replacement Therapy and Undergone Hysterectomy/Bilateral Oophorectomy.
Lead sponsor
Warner Chilcott
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2002
Completion date
July 31, 2006
Enrollment
562 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypoactive sexual desire disorder